Patient Safety and Risk Management Software Market Size, Share, Growth Analysis, By Product(governance, risk and compliance solutions, claim management solution and others), By End user(hospitals, outpatient treatment centers and others), By Region - Industry Forecast 2024-2031

The Global Patient Safety and Risk Management Software Market is highly fragmented with the presence of several small and large market players operating all over the world. Major companies of the market are implementing several business strategies such as new product launches, acquisition & mergers, collaboration, and partnerships for the expansion of their geographical presence and their product portfolio.

Patient Safety and Risk Management Software Market Top Players Company Profiles 

• RLDatix
• Verge Health
• Datix Limited
• Riskonnect, Inc.
• Clarity Group Inc.
• Quantros, Inc.
• The Patient Safety Company
• Prista Corporation
• The RL Solutions
• Morrisey, A HealthStream Company
• RiskQual Technologies
• MRM Group
• Berry Systems
• LogicManager, Inc.
• Vistar Technologies
• Conduent
• Riskwise
• MRM Group LLC
• MetricStream
• RiskMan International

Patient Safety and Risk Management Software Market Recent Developments

• ThinkQA Secondary Dose Check is a new software tool that allows patients' secondary dosages to be verified and calculated. It was launched by DOSIsoft in May 2023. It is intended to support Radiation Therapy (RT) departments in achieving the quality assurance (QA) standards of the most recent adaptive radiotherapy tools and processes as well as patient-specific safety and QA procedures. 
• Conduent Inc. introduced CommunityVision in April 2021 in response to providers' growing emphasis on lowering health disparities—differences in health and healthcare between populations brought on by social, economic, and/or environmental disadvantages. CommunityVision is distinct in that it integrates important data on socioeconomic factors into the care team's workflow.If the care team has a greater grasp of the community concerns that may affect their patients, they can get closer to achieving the Triple Aim with the right solution for the right patient at the right time.